Suscripción a Biblioteca: Guest
Critical Reviews™ in Biomedical Engineering

Publicado 6 números por año

ISSN Imprimir: 0278-940X

ISSN En Línea: 1943-619X

SJR: 0.262 SNIP: 0.372 CiteScore™:: 2.2 H-Index: 56

Indexed in

Pharmacokinetic/Pharmacodynamic Modeling in Inflammation

Volumen 40, Edición 4, 2012, pp. 295-312
DOI: 10.1615/CritRevBiomedEng.v40.i4.50
Get accessGet access

SINOPSIS

Inflammation is an array of immune responses to infection and injury. It results from a complex immune cascade and is the basis of many chronic diseases such as arthritis, diabetes, and cancer. Numerous mathematical models have been developed to describe the disease progression and effects of anti-inflammatory drugs. This review illustrates the state of the art in modeling the effects of diverse drugs for treating inflammation, describes relevant biomarkers amenable to modeling, and summarizes major advantages and limitations of the published pharmacokinetic/ pharmacodynamic (PK/PD) models. Simple direct inhibitory models are often used to describe in vitro effects of anti-inflammatory drugs. Indirect response models are more mechanism based and have been widely applied to the turnover of symptoms and biomarkers. These, along with target-mediated and transduction models, have been successfully applied to capture the PK/PD of many anti-inflammatory drugs and describe disease progression of inflammation. Biologics have offered opportunities to address specific mechanisms of action, and evolve small systems models to quantitatively capture the underlying physiological processes. More advanced mechanistic models should allow evaluation of the roles of some key mediators in disease progression, assess drug interactions, and better translate drug properties from in vitro and animal data to patients.

CITADO POR
  1. Jusko William J., Moving from Basic Toward Systems Pharmacodynamic Models, Journal of Pharmaceutical Sciences, 102, 9, 2013. Crossref

  2. Lon Hoi-Kei, Liu Dongyang, DuBois Debra C., Almon Richard R., Jusko William J., Modeling pharmacokinetics/pharmacodynamics of abatacept and disease progression in collagen-induced arthritic rats: a population approach, Journal of Pharmacokinetics and Pharmacodynamics, 40, 6, 2013. Crossref

  3. Gabrielsson Johan, Hjorth Stephan, Vogg Barbara, Harlfinger Stephanie, Gutierrez Pablo Morentin, Peletier Lambertus, Pehrson Rikard, Davidsson Pia, Modeling and design of challenge tests: Inflammatory and metabolic biomarker study examples, European Journal of Pharmaceutical Sciences, 67, 2015. Crossref

  4. Ti Dongdong, Hao Haojie, Xia Lei, Tong Chuan, Liu Jiejie, Dong Liang, Xu Shenjun, Zhao Yali, Liu Huiling, Fu Xiaobing, Han Weidong, Controlled Release of Thymosin Beta 4 Using a Collagen–Chitosan Sponge Scaffold Augments Cutaneous Wound Healing and Increases Angiogenesis in Diabetic Rats with Hindlimb Ischemia, Tissue Engineering Part A, 21, 3-4, 2015. Crossref

  5. Shah Dhaval K., Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics, Journal of Pharmacokinetics and Pharmacodynamics, 42, 5, 2015. Crossref

  6. Danhof Meindert, Systems pharmacology – Towards the modeling of network interactions, European Journal of Pharmaceutical Sciences, 94, 2016. Crossref

  7. Liang Si-Cheng, Xia Yang-Liu, Hou Jie, Ge Guang-Bo, Zhang Jiang-Wei, He Yu-Qi, Wang Jia-Yue, Qi Xiao-Yi, Yang Ling, Methylation, Glucuronidation, and Sulfonation of Daphnetin in Human Hepatic Preparations In Vitro : Metabolic Profiling, Pathway Comparison, and Bioactivity Analysis, Journal of Pharmaceutical Sciences, 105, 2, 2016. Crossref

  8. Scheff Jeremy D., Kamisoglu Kubra, Androulakis Ioannis P., Mechanistic Modeling of Inflammation, in Systems Pharmacology and Pharmacodynamics, 23, 2016. Crossref

  9. Christley Scott, Cockrell Chase, An Gary, Computational Studies of the Intestinal Host-Microbiota Interactome, Computation, 3, 1, 2015. Crossref

  10. Świerczek Artur, Wyska Elżbieta, Baś Sebastian, Woyciechowska Marta, Mlynarski Jacek, PK/PD studies on non-selective PDE inhibitors in rats using cAMP as a marker of pharmacological response, Naunyn-Schmiedeberg's Archives of Pharmacology, 390, 10, 2017. Crossref

  11. Tabrizi Mohammad A., Sadekar Shraddha S., Figueroa Isabel, Ovacik Ayse M., Stimulus-Response Mechanisms: An Overview, in Development of Antibody-Based Therapeutics, 2018. Crossref

  12. Brunet Mercè, van Gelder Teun, Åsberg Anders, Haufroid Vincent, Hesselink Dennis A., Langman Loralie, Lemaitre Florian, Marquet Pierre, Seger Christoph, Shipkova Maria, Vinks Alexander, Wallemacq Pierre, Wieland Eberhard, Woillard Jean Baptiste, Barten Markus J., Budde Klemens, Colom Helena, Dieterlen Maja-Theresa, Elens Laure, Johnson-Davis Kamisha L., Kunicki Paweł K., MacPhee Iain, Masuda Satohiro, Mathew Binu S., Millán Olga, Mizuno Tomoyuki, Moes Dirk-Jan A. R., Monchaud Caroline, Noceti Ofelia, Pawinski Tomasz, Picard Nicolas, van Schaik Ron, Sommerer Claudia, Vethe Nils Tore, de Winter Brenda, Christians Uwe, Bergan Stein, Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report, Therapeutic Drug Monitoring, 41, 3, 2019. Crossref

  13. Skaria Tom, Bachli Esther, Schoedon Gabriele, Gene Ontology Analysis for Drug Targets of the Whole Genome Transcriptome of Human Vascular Endothelial Cells in Response to Proinflammatory IL-1, Frontiers in Pharmacology, 10, 2019. Crossref

  14. Vicini Paolo, Standifer Nathan, Hickling Timothy P., Recruiting the Immune System Against Disease: Lessons for Clinical and Systems Pharmacology, CPT: Pharmacometrics & Systems Pharmacology, 2019. Crossref

  15. Prasad Bhagwat, Evers Raymond, Gupta Anshul, Hop Cornelis E. C. A., Salphati Laurent, Shukla Suneet, Ambudkar Suresh V., Unadkat Jashvant D., Interindividual Variability in Hepatic Organic Anion-Transporting Polypeptides and P-Glycoprotein (ABCB1) Protein Expression: Quantification by Liquid Chromatography Tandem Mass Spectroscopy and Influence of Genotype, Age, and Sex, Drug Metabolism and Disposition, 42, 1, 2014. Crossref

  16. Chen Xi, DuBois Debra C., Almon Richard R., Jusko William J., Interrelationships between Infliximab and Recombinant Tumor Necrosis Factor-αin Plasma Using Minimal Physiologically Based Pharmacokinetic Models, Drug Metabolism and Disposition, 45, 7, 2017. Crossref

  17. Menon Sujatha, Krishnaswami Sriram, Pharmacometric Applications in Inflammation, in Applied Pharmacometrics, 14, 2014. Crossref

  18. Loisios-Konstantinidis Ioannis, Paraiso Rafael L M, Fotaki Nikoletta, McAllister Mark, Cristofoletti Rodrigo, Dressman Jennifer, Application of the relationship between pharmacokinetics and pharmacodynamics in drug development and therapeutic equivalence: a PEARRL review, Journal of Pharmacy and Pharmacology, 71, 4, 2019. Crossref

  19. Ullah Md. Asad, Johora Fatema Tuz, Sarkar Bishajit, Araf Yusha, Rahman MD. Hasanur, Curcumin analogs as the inhibitors of TLR4 pathway in inflammation and their drug like potentialities: a computer-based study, Journal of Receptors and Signal Transduction, 40, 4, 2020. Crossref

  20. Kamat Vinuta, Santosh Rangappa, Poojary Boja, Nayak Suresh P., Kumar Banoth Karan, Sankaranarayanan Murugesan, Faheem , Khanapure Sheela, Barretto Delicia Avilla., Vootla Shyam K., Pyridine- and Thiazole-Based Hydrazides with Promising Anti-inflammatory and Antimicrobial Activities along with Their In Silico Studies, ACS Omega, 5, 39, 2020. Crossref

  21. Oliveira Gabriela Moraes, Dionísio Thiago José, Siqueira-Sandrin Viviane Silva, Ferrari Leticia Alves de Lima, Bolani Bruna, Parisi Viviane Aparecida, Polanco Nelson Leonel Del Hierro, Colombini-Ishikiriama Bella Luna, Faria Flávio Augusto Cardoso, Santos Carlos Ferreira, Calvo Adriana Maria, CYP2C9 Polymorphism Influence in PK/PD Model of Naproxen and 6-O-Desmethylnaproxen in Oral Fluid, Metabolites, 12, 11, 2022. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain